Literature DB >> 34114940

The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2.

Wael Alturaiki1, Ayman Mubarak2, Abduallah Al Jurayyan3, Maged Gomaa Hemida4,5.   

Abstract

SARS-CoV2 infection induces various degrees of infections ranging from asymptomatic to severe cases and death. Virus/host interplay contributes substantially to these outcomes. This highlights the potential roles of the host immune system in fighting virus infections. SARS-CoV-2. We highlighted the potential roles of host immune response in the modulation of the outcomes of SARS-CoV infections. The newly emerged SARS-CoV-2 mutants complicated the control and mitigation strategies measures. We are highlighting the current progress of some already deployed vaccines worldwide as well as those still in the pipelines. Recent studies from the large ongoing global vaccination campaign are showing promising results in reducing the hospitality rates as well as the number of severe SARS-CoV-2 infected patients. Careful monitoring of the genetic changes of the virus should be practiced. This is to prepare some highly sensitive diagnostic assays as well as to prepare some homologous vaccines matching the circulating strains in the future.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; adaptive immunity; escape mutation; immune evasion; immune response; innate immunity; vaccines

Year:  2021        PMID: 34114940      PMCID: PMC8204314          DOI: 10.1080/21645515.2021.1935172

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  109 in total

1.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.

Authors:  Divij Mathew; Josephine R Giles; Amy E Baxter; Derek A Oldridge; Allison R Greenplate; Jennifer E Wu; Cécile Alanio; Leticia Kuri-Cervantes; M Betina Pampena; Kurt D'Andrea; Sasikanth Manne; Zeyu Chen; Yinghui Jane Huang; John P Reilly; Ariel R Weisman; Caroline A G Ittner; Oliva Kuthuru; Jeanette Dougherty; Kito Nzingha; Nicholas Han; Justin Kim; Ajinkya Pattekar; Eileen C Goodwin; Elizabeth M Anderson; Madison E Weirick; Sigrid Gouma; Claudia P Arevalo; Marcus J Bolton; Fang Chen; Simon F Lacey; Holly Ramage; Sara Cherry; Scott E Hensley; Sokratis A Apostolidis; Alexander C Huang; Laura A Vella; Michael R Betts; Nuala J Meyer; E John Wherry
Journal:  Science       Date:  2020-07-15       Impact factor: 47.728

2.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

3.  Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.

Authors:  Pedro M Folegatti; Mustapha Bittaye; Amy Flaxman; Fernando Ramos Lopez; Duncan Bellamy; Alexandra Kupke; Catherine Mair; Rebecca Makinson; Jonathan Sheridan; Cornelius Rohde; Sandro Halwe; Yuji Jeong; Young-Shin Park; Jae-Ouk Kim; Manki Song; Amy Boyd; Nguyen Tran; Daniel Silman; Ian Poulton; Mehreen Datoo; Julia Marshall; Yrene Themistocleous; Alison Lawrie; Rachel Roberts; Eleanor Berrie; Stephan Becker; Teresa Lambe; Adrian Hill; Katie Ewer; Sarah Gilbert
Journal:  Lancet Infect Dis       Date:  2020-04-21       Impact factor: 25.071

4.  Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection.

Authors:  Hyoung-Shik Shin; Yeonjae Kim; Gayeon Kim; Ji Yeon Lee; Ina Jeong; Joon-Sung Joh; Hana Kim; Eunjin Chang; Soo Yeon Sim; Jun-Sun Park; Dong-Gyun Lim
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

5.  Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

Authors:  Yiska Weisblum; Fabian Schmidt; Fengwen Zhang; Justin DaSilva; Daniel Poston; Julio Cc Lorenzi; Frauke Muecksch; Magdalena Rutkowska; Hans-Heinrich Hoffmann; Eleftherios Michailidis; Christian Gaebler; Marianna Agudelo; Alice Cho; Zijun Wang; Anna Gazumyan; Melissa Cipolla; Larry Luchsinger; Christopher D Hillyer; Marina Caskey; Davide F Robbiani; Charles M Rice; Michel C Nussenzweig; Theodora Hatziioannou; Paul D Bieniasz
Journal:  Elife       Date:  2020-10-28       Impact factor: 8.140

6.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

Review 7.  COVID-19: Coronavirus Vaccine Development Updates.

Authors:  Jing Zhao; Shan Zhao; Junxian Ou; Jing Zhang; Wendong Lan; Wenyi Guan; Xiaowei Wu; Yuqian Yan; Wei Zhao; Jianguo Wu; James Chodosh; Qiwei Zhang
Journal:  Front Immunol       Date:  2020-12-23       Impact factor: 7.561

Review 8.  Recent Advances in Zika Virus Vaccines.

Authors:  Himanshu Garg; Tugba Mehmetoglu-Gurbuz; Anjali Joshi
Journal:  Viruses       Date:  2018-11-14       Impact factor: 5.048

9.  The SARS-CoV-2 outbreak from a one health perspective.

Authors:  Maged Gomaa Hemida; Mohammed M Ba Abduallah
Journal:  One Health       Date:  2020-03-16

10.  Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.

Authors:  Sheng-Fan Wang; Sung-Pin Tseng; Chia-Hung Yen; Jyh-Yuan Yang; Ching-Han Tsao; Chun-Wei Shen; Kuan-Hsuan Chen; Fu-Tong Liu; Wu-Tse Liu; Yi-Ming Arthur Chen; Jason C Huang
Journal:  Biochem Biophys Res Commun       Date:  2014-07-26       Impact factor: 3.575

View more
  3 in total

1.  Durability of SARS-CoV-2 Specific IgG Antibody Responses Following Two Doses of Match and Mixed COVID-19 Vaccines Regimens in Saudi Population.

Authors:  Ayman Mubarak; Saeedah Almutairi; Abulrahman D Al-Dhabbah; Shaha Y Aldabas; Rauf Bhat; Mahfoudh M Alqoufail; Mostafa A Abdel-Maksoud; Taghreed N Almanaa; Mohamed A Farrag; Wael Alturaiki
Journal:  Infect Drug Resist       Date:  2022-07-15       Impact factor: 4.177

Review 2.  Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy.

Authors:  Zhangkai J Cheng; Bizhou Li; Zhiqing Zhan; Zifan Zhao; Mingshan Xue; Peiyan Zheng; Jiali Lyu; Chundi Hu; Jianxing He; Ruchong Chen; Baoqing Sun
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

Review 3.  Considerations for Novel COVID-19 Mucosal Vaccine Development.

Authors:  Wael Alturaiki
Journal:  Vaccines (Basel)       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.